BETHLEHEM, Pa., Feb. 22, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that its OraQuick ® HCV Rapid Antibody Test has now been approved by the U.S. Food and Drug ...

As investors packed up in search of more exciting prospects, shares of OraSure Technologies (NASDAQ:OSUR) have been slashed in half since their highs in mid-2012, in fact, setting a new 52-week low ...

BETHLEHEM, Pa., March 23, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that it has submitted to the U.S. Food and Drug Administration ("FDA") an application for a ...

Says filing for oral version of HCV test delayed Says FDA commented on lower sensitivity of tests Q2 loss/shr $0.01 vs. est loss/shr $0.07 Q2 rev $19.2 mln vs. est $17.5 mln Aug 4 (Reuters) - OraSure ...

The Chronic Liver Disease Foundation (CLDF) announced today that it's collaborating with Walgreens to offer free hepatitis C (HCV) testing with the OraQuick® HCV Rapid Test at more than 60 Walgreens ...

BETHLEHEM — OraSure Technologies and drugmaker AbbVie have agreed to end an agreement under which the companies have been co-promoting OraSure’s OraQuick HCV Rapid Antibody Test in the U.S. The ...

Bethlehem, PA-based OraSure Technologies (NASDAQ:OSUR) has received the FDA's OK for its OraQuick hepatitis C rapid antibody test. It is the the first rapid HCV test approved by the FDA for use in the ...

A partnership between OraSure Technologies (Bethlehem, Pennsylvania) and AbbVie (North Chicago) could put testing individuals at-risk for hepatitis C (HCV) in the forefront of testing for the disease.

In two separate moves, the FDA has approved the first assay to detect both antigen and antibodies to HIV and the first rapid blood test for hepatitis C virus (HCV) antibodies. The Architect HIV Ag/Ab ...

Over the past 27 years, our greatest tool in battling the HIV virus has barely changed. Until now. A Pennsylvania biotech company is currently awaiting FDA approval for the first ever over-the-counter ...

The FDA recently approved the use of blood obtained from a finger stick for a hepatitis C virus (HCV) test, potentially enabling health care providers to identify more individuals who have the ...

OraSure Technologies has submitted an application to the U.S. Food and Drug Administration for approval of a rapid hepatitis C test, according to a news release. The Bethlehem-based company is seeking ...